Research programme: antiviral nucleotides - Alios BioPharma
Alternative Names: AL-516; Guanosine analogue - Alios BioPharmaLatest Information Update: 28 Oct 2018
At a glance
- Originator Alios BioPharma
- Class Nucleotides
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C